PIBF1 and neoplasm: In conclusion, our findings indicate that decreased expression of miR-203 is associated with tumor size, poor prognosis and recurrence in GC patients, and miR-203 overexpression suppresses the GC growth by targeting PIBF1/Akt signaling, suggesting that miR-203 may have the important therapeutic potential for treatment of GC.